Αποτελέσματα Αναζήτησης
Clinical management of multiple sclerosis around the world. Key findings about the diagnosis and clinical management of MS. April 2021. About this report.
17 Οκτ 2024 · MS is a neurological condition that affects nearly 1 million U.S. adults, reports the National MS Society. New medications have slowed the progression of the condition. People with MS...
Prognostic Factors in Multiple Sclerosis. Prediction of highly active disease and rapid disability accumulation is crucial to optimizing clinical outcomes over time. Adrian Espiritu, MD; and Jiwon Oh, MD, PhD. View/Print PDF View References.
Multiple Sclerosis (MS) is an incurable, chronic disease afecting the Central Nervous System (CNS) in which the body’s own immune system mistakenly attacks and damages the fatty material – called myelin – around the nerves.
Prediction of highly active disease and rapid disability accumulation is crucial to optimizing clinical outcomes over time.
26 Απρ 2024 · Multiple sclerosis (MS) is the most common immune-mediated inflammatory demyelinating disease of the central nervous system. The onset and phenotypes of MS will be reviewed here. Clinical symptoms and signs of MS are reviewed elsewhere.
26 Οκτ 2023 · The current guidelines review the current diagnostic criteria for MS and the scientific evidence supporting treatment of acute relapses, radiologically isolated syndrome, clinically isolated syndrome, relapsing remitting MS, progressive MS, pediatric cases and pregnant women.
